Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

ABSTRACT:

SUBMITTER: Papalexandri A 

PROVIDER: S-EPMC10671524 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature